Skip to main content
Premium Trial:

Request an Annual Quote

Precipio Issues $1.9M in Shares to Cancel Debt

NEW YORK (GenomeWeb) – Precipio announced late on Tuesday it issued more than 1.8 million shares of its common stock in order to cancel debt totaling $1.9 million.

In a document filed with the US Securities and Exchange Commission, the company said that it issued the shares on Feb. 12 to several of its trade creditors to settle the debt. Precipio did not identify the creditors.

Separately, the company said in an SEC document last week that it had reached a deal with Leviston Resources to sell it, from time to time, shares of Precipio's common stock having an aggregate offering price of up to $8 million.

Last week, the company also announced preliminary fourth quarter revenues of $945,000, a 200 percent increase year over year from the year-ago period.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.